We are live on ! Find out more
WGSWW

GeneDx Holdings Warrant
WGSWW

Delisted

WGSWW was delisted on the 21st of July, 2026.

Back to rankings

35 hedge funds and large institutions have $15.6M invested in GeneDx Holdings Warrant in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 3

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

40% more funds holding

Funds holding: 25 → 35 (+10)

41% less capital invested

Capital invested by funds: $26.5M → $15.6M (-$10.9M)

Holders
35
Holders Change
+10
Holders Change %
+40%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
7
Reduced
4
Closed
3
Calls
$613K
Puts
–
Net Calls
+$613K
Net Calls Change
-$372K

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$2.29M
2
BCP
Berylson Capital Partners
Massachusetts
+$1.1M
3
ICM
Ionic Capital Management
New York
+$901K
4
GS
Gagnon Securities
New York
+$720K
5
DCP
Diameter Capital Partners
New York
+$529K

Top Sellers

Rank Fund Capital Flow
1
MCM
Moore Capital Management
New York
-$1.38M
2
MF
Magnetar Financial
Illinois
-$537K
3
DKCM
Davidson Kempner Capital Management
New York
-$381K
4
AC
Athanor Capital
New York
-$310K
5
AA
AQR Arbitrage
Connecticut
-$233K
Name Holding Trade Value Shares
Change 		Change in
Stake
SHCM
1
Sachem Head Capital Management
New York
$2.45M – – –
ICM
2
Ionic Capital Management
New York
$2.13M +$901K +274,024 +38%
Blackstone Inc
3
Blackstone Inc
New York
$1.5M – – –
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$1.48M +$2.29M +696,994 New
LA
5
Linden Advisors
New York
$1.45M – – –
D.E. Shaw & Co
6
D.E. Shaw & Co
New York
$1.06M – – –
BCP
7
Berylson Capital Partners
Massachusetts
$707K +$1.1M +333,333 New
Wellington Management Group
8
Wellington Management Group
Massachusetts
$687K – – –
6CM
9
683 Capital Management
New York
$530K – – –
GS
10
Gagnon Securities
New York
$521K +$720K +218,989 +812%
JG
11
Jefferies Group
New York
$377K +$109K +33,308 +23%
AC
12
Athanor Capital
New York
$366K -$310K -94,159 -66%
DCP
13
Diameter Capital Partners
New York
$341K +$529K +160,859 New
MIM
14
Monashee Investment Management
Massachusetts
$283K – – –
BFM
15
Boothbay Fund Management
New York
$270K +$117K +35,711 New
GA
16
Gagnon Advisors
New York
$262K +$406K +123,469 New
MP
17
MSD Partners
New York
$212K +$329K +100,000 New
M
18
Murchinson
Ontario, Canada
$155K -$170K -51,800 -41%
AC
19
Aristeia Capital
Connecticut
$152K +$233K +71,024 New
LP
20
LMR Partners
United Kingdom
$118K +$329 +100 +0.6%
AGM
21
Alpine Global Management
New York
$85K +$65.6K +19,950 +100%
MF
22
Magnetar Financial
Illinois
$79K -$537K -163,377 -81%
HF
23
HRT Financial
New York
$76K +$119K +36,256 New
ACM
24
Arrow Capital Management
New York
$74K – – –
CCM
25
Context Capital Management
California
$58K – – –
1
2

WGSWW Hedge Fund Activity: Q3 2021 in Review

35 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q3 2021, worth a combined $15.6M — down 41% from $26.5M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new WGSWW positions and 3 closed out — a net gain of 10 holders — while 7 added to existing stakes and 4 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $2.29M. The largest seller was Moore Capital Management, exiting entirely with an estimated $1.38M sold.

  • 35 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q3 2021, up from 25 in Q2 2021.
  • Funds reported $15.6M of GeneDx Holdings Warrant stock for Q3 2021, down 41% quarter-over-quarter.
  • 13 funds opened new GeneDx Holdings Warrant positions in Q3 2021 and 3 closed out, a net change of +10 holders.
  • The largest GeneDx Holdings Warrant buyer in Q3 2021 was T. Rowe Price Associates, an estimated $2.29M added.
  • The largest GeneDx Holdings Warrant seller in Q3 2021 was Moore Capital Management, an estimated $1.38M sold.

Based on aggregated 13F filings for Q3 2021.